Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer

Endocrinol Metab Clin North Am. 1990 Sep;19(3):685-718.

Abstract

131I continues to be one of the safest and most effective methods of diagnosing and treating metastatic well differentiated thyroid cancer. It is not without risk, however, and must be judiciously applied to carefully prepared and selected patients.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / radiotherapy
  • Adjuvants, Pharmaceutic
  • Bone and Bones / drug effects
  • Carcinoma, Papillary* / diagnosis
  • Carcinoma, Papillary* / radiotherapy
  • Gonads / drug effects
  • Humans
  • Iodine Radioisotopes* / adverse effects
  • Lithium / pharmacology
  • Lymphatic Metastasis / diagnosis
  • Neoplasm Metastasis / diagnosis
  • Neoplasm Recurrence, Local
  • Pneumonia / etiology
  • Salivary Glands / drug effects
  • Thyroid Gland / drug effects
  • Thyroid Neoplasms* / diagnosis
  • Thyroid Neoplasms* / radiotherapy
  • Vocal Cords / drug effects

Substances

  • Adjuvants, Pharmaceutic
  • Iodine Radioisotopes
  • Lithium